Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Salix Pharmaceuticals Ltd (SLXP)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: SLXP
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
FDA Calendar Extreme Trades: 85 Single Digit Stocks
Oct 14
•
Mike Havrilla
•
4 Comments
Salix: Approval of Rifaximin Would Help Drive Long-Term Growth
Sep 29
•
Zacks.com
•
Comment!
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Sep 20
•
Justin M. Hall
•
3 Comments
Closing Update: Stocks Manage Narrowly Higher Finish
Sep 14
•
Midnight Trader
•
3 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Sep 11
•
Justin M. Hall
•
23 Comments
Salix Pharma Continues to Rise in Anticipation of FDA Decision
Sep 6
•
M. E. Garza
•
Comment!
Pending FDA Decisions: 20 Extreme Trades
Jun 22
•
Mike Havrilla
•
13 Comments
FDA, Clinical Trial Updates: Biogen, Roche, Salix, Cell Therapeutics, Pfizer
May 20
•
Mike Havrilla
•
3 Comments
FDA, Clinical Trial Calendar Updates: WYE, SVNT, AMRN, ISIS, SLXP, SOMX
May 8
•
Mike Havrilla
•
Comment!
Monday Options Update: AMAG, XME, THOR, MSFT, SLXP, CEG, ING, RIMM
Oct 20, 2008
•
Andrew Wilkinson
•
2 Comments
Ten Must-Know Stories for Monday
Dec 31, 2007
•
SA Editor Eli Hoffmann
•
Comment!
Biotech Day in Review: Xoma Signs $230 Million Partnership with Takeda
Mar 1, 2007
•
Centient Biotech Investor
•
Comment!